Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Proper diagnosis and treatment of childhood hair loss require distinguishing between alopecia and trichotillomania.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

The document says hair loss can happen after recovering from COVID-19 and it can cause psychological discomfort.

Pediatric alopecia areata needs better treatments and psychological support.

Men with hair loss are seen as less attractive and shorter, and height is a key factor in attractiveness ratings.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Many women's hair loss is due to health issues, medication, nutrition, or stress.

Biocompatible artificial hair implants significantly improved patients' quality of life and were successful.

Biocompatible artificial hair is safe, effective, and improves quality of life for alopecia patients.

Post-finasteride syndrome is rare but serious and should be taken seriously.

Female pattern hair loss greatly affects women's quality of life, causing mild depression and anxiety, and increases medical expenses.

New hair loss treatments could be improved by using combined biological markers.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Women are more likely to have long-term post-COVID symptoms than men.

Shift work disrupts the body's natural clock, leading to health problems.

Anorexia nervosa can cause skin problems, which may help with early diagnosis and usually improve with treatment.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Targeting psychosocial factors can help reduce self-stigma in people with chronic skin diseases.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.